{"indicator":"3.d.2","layout":"indicator","permalink":"/3-d-2/","sdg_goal":"3","target_id":"3.d","published":true,"target_name":"Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks","computation_definitions":"<b> Estimated data by international organizations (Type2) </b>   <br> This is Korean data prepared by international organizations through estimation and modeling. <br> If there are no national data corresponding to UN SDGs indicators, international data are available for monitoring.","indicator_name":"Percentage of bloodstream infections due to selected antimicrobial-resistant organisms","indicator_definition":"Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli resistant to 3rd-generation cephalosporin among patients seeking care and whose blood sample is taken and tested. ","computation_calculations":"\uad6d\uac00 \ud56d\uc0dd\uc81c \ub0b4\uc131(AMR) \uac10\uc2dc \uc2dc\uc2a4\ud15c\uc744 \ud1b5\ud574 \uc218\uc9d1\ub418\uc5b4 WHO GLASS(\uc138\uacc4\ubcf4\uac74\uae30\uad6c \uae00\ub85c\ubc8c \ud56d\uc0dd\uc81c \ub0b4\uc131 \uac10\uc2dc\uccb4\uacc4)\uc5d0 \ubcf4\uace0\ub41c \ub370\uc774\ud130\ub97c \uc9d1\uacc4","global_indicator_name":"Percentage of bloodstream infections due to selected antimicrobial-resistant organisms","un_designated_tier":"I","un_custodian_agency":"WHO","goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0d-02.pdf","goal_meta_link_text":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0d-02.pdf","goal_meta_local_link":"https://kostat-sdg-kor.github.io/sdg-indicators/public/data/Metadata-03-0d-02_ENG.pdf","goal_meta_local_link_text":"https://kostat-sdg-kor.github.io/sdg-indicators/public/data/Metadata-03-0d-02_ENG.pdf","reporting_status":"complete","data_non_statistical":false,"graph_type":"line","graph_title":"Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) & Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%)","computation_units":"\ud37c\uc13c\ud2b8(%)","national_geographical_coverage":"\uc804\uccb4","source_active_1":true,"source_organisation_1":"WHO","source_active_2":true,"source_active_3":false,"source_active_4":false,"source_active_5":false,"source_active_6":false,"indicator_sort_order":"03-dd-02","data_show_map":false,"source_url_text_1":"Link to source","source_url_text_2":"Link to Source","source_url_3":"Link to source","source_url_text_4":"Link to source","source_url_text_5":"Link to source","source_url_text_6":"Link to source","source_active_7":false,"source_url_text_7":"Link to source","source_active_8":false,"source_url_text_8":"Link to source","source_active_9":false,"source_url_text_9":"Link to source","title":"Untitled","page_content":""}